Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Immunology Letters|July 19, 2017
The anti-tumor activity of the STAT3 inhibitor STX-0119 occurs via promotion of tumor-infiltrating lymphocyte accumulation in temozolomide-resistant glioblastoma cell lineYasuto Akiyama, Chizu Nonomura, Tadashi Ashizawa, et al.
BMC Cancer|December 29, 2012
α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trialYasuto Akiyama, Chie Oshita, Akiko Kume, et al.
Oncology Reports|August 17, 2012
Dendritic cell-based vaccination in metastatic melanoma patients: phase II clinical trialChie Oshita, Masako Takikawa, Akiko Kume, et al.
In Vivo (Athens, Greece)|December 31, 2024
In Vivo Antitumor Activity of the PD-1/PD-L1 Inhibitor SCL-1 in Various Mouse Tumor ModelsTadashi Ashizawa, Akira Iizuka, Akari Kanematsu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2016
Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout MouseTadashi Ashizawa, Akira Iizuka, Chizu Nonomura, et al.
Oncology Reports|December 30, 2017
Immune response-associated gene profiling in Japanese melanoma patients using multi-omics analysisYasuto Akiyama, Yoshio Kiyohara, Shusuke Yoshikawa, et al.
Cancer Genomics & Proteomics|April 25, 2025
Characterization of the Neoantigen Profile in a Tumor Mutation Burden-high Melanoma Patient With Multiple MetastasesShusuke Yoshikawa, Chie Maeda, Akira Iizuka, et al.
Immunology Letters|October 7, 2019
Impact of combination therapy with anti-PD-1 blockade and a STAT3 inhibitor on the tumor-infiltrating lymphocyte statusTadashi Ashizawa, Akira Iizuka, Chie Maeda, et al.
Anticancer Research|March 19, 2017
Multi-omics Profiling of Patients with Melanoma Treated with Nivolumab in Project HOPEShusuke Yoshikawa, Yoshio Kiyohara, Masaki Otsuka, et al.
Oncology Reports|February 28, 2014
Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patientsYasuto Akiyama, Masaru Komiyama, Haruo Miyata, et al.
Pageof 5